Michal Votruba - May 19, 2022 Form 4 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role: Director
Signature: /s/ Richard I. Steinhart, Attorney-in-Fact for Michal Votruba
Stock symbol: BTAI
Transactions as of: May 19, 2022
Transactions value $: $0
Form type: 4
Date filed: 5/23/2022, 06:48 PM
Previous filing: Jun 15, 2021
Next filing: Jun 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BTAI	Stock Option (Right to Buy)	Award	$0	+17K		$0.00	17K	May 19, 2022	Common Stock	17K	$13.24	Direct	F1, F2
transaction	BTAI	Stock Option (Right to Buy)	Other	$0	-17K	-100%	$0.00^*	0	May 19, 2022	Common Stock	17K	$13.24	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund ("RSJ") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person does not beneficially own any of the securities reported herein.
F2	The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date.

Content

The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund ("RSJ") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person does not beneficially own any of the securities reported herein.

The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date.